封面
市場調查報告書
商品編碼
1675175

2025年全球直接面對消費者(DTC)基因檢測市場報告

Direct-To-Consumer (DTC) Genetic Testing Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年直接面對消費者(DTC)基因檢測市場規模將快速成長。到 2029 年,這一數字將成長至 39 億美元,複合年成長率為 16.2%。預測期內的成長可歸因於擴大檢測範圍、與個人化醫療的整合、與健康和保健產業的合作、基因研究的進步、政府支持和監管。預測期內的關鍵趨勢包括測試服務和小組的擴大、消費者教育工作、法規遵循和監督、基因組資料監測和貢獻、價格降低和可訪問性。

預計未來幾年,與基因傳播有關的疾病和病症的日益普及將推動直接面對消費者 (DTC) 基因檢測市場的成長。遺傳性疾病被定義為由人體 DNA 變化(突變)引起的疾病,包括單基因、多因子和染色體疾病。直接面對消費者的基因檢測提高了人們對各種遺傳疾病的認知,幫助個人制定健康預測,並提供有關健康狀況、疾病風險和其他特徵的個人化資訊。這些資訊將支持旨在降低疾病風險的有效健康和生活方式選擇。例如,美國醫學圖書館-國家醫學圖書館(NLM)在2023年4月報告稱,預計約有670萬65歲及以上的美國將患上老年失智症失智症(AD),而這種疾病很大程度上受到遺傳因素的影響。除非在預防、減緩或治療 AD 方面取得醫學突破,否則到 2060 年,這一數字可能會上升到 1,380 萬。因此,遺傳疾病和病症的日益普及正在推動直接面對消費者 (DTC) 基因檢測市場的擴張。

數位健康解決方案的擴展預計將在短期內推動直接面對消費者 (DTC) 基因檢測市場的成長。數位健康利用技術來增強醫療保健、改善患者治療效果、簡化流程並幫助個人管理自己的健康。 DTC 基因檢測透過積極吸引消費者、整合基因資料實現個人化、促進遠端醫療服務、連接穿戴式裝置以及倡導預防性護理,在數位健康成長中發揮關鍵作用。美國專業組織美國醫學會 (美國 Medical Association) 在 2022 年 9 月的報告中重點介紹了這一趨勢的一個例子。報告顯示,認為數位健康工具有益於病患照護的醫師比例將大幅增加,從2016年的85%增加到2022年的93%。此外,醫生使用的數位健康工具的平均數量也將顯著成長,從2016年的2.2個增加到2022年的3.8個。因此,數位健康解決方案的普及正在推動直接面對消費者(DTC)基因檢測市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情境 宏觀經濟情境包括利率、通膨、地緣政治、新冠疫情和市場復甦的影響

第5章 全球成長分析與策略分析框架

  • 全球直接面對消費者(DTC)基因檢測PESTEL分析(政治、社會、科技、環境、法律、促進因素、限制因素)
  • 最終用途產業分析
  • 全球直接面對消費者(DTC)基因檢測市場:成長率分析
  • 全球直接面對消費者 (DTC) 基因檢測市場表現:規模與成長,2019-2024 年
  • 全球直接面對消費者 (DTC) 基因檢測市場預測:規模與成長,2024-2029 年,2034 年預測
  • 全球直接面對消費者 (DTC) 基因檢測總目標市場 (TAM)

第6章市場區隔

  • 全球直接面對消費者 (DTC) 基因檢測市場類型、績效及預測(2019-2024 年、2024-2029 年及 2034 年)
  • 職業測試
  • 預測測試
  • 血統和關係測試
  • 營養基因體學檢測
  • 其他類型
  • 全球直接面對消費者 (DTC) 基因檢測市場樣本、績效及預測(2019-2024 年、2024-2029 年及 2034 年)
  • 唾液
  • 尿
  • 全球直接面對消費者 (DTC) 基因檢測市場(按技術、性能和預測),2019-2024 年、2024-2029 年、2034 年
  • 單核苷酸多態性晶片
  • 全基因組序列分析
  • 目標分析
  • 全球直接面對消費者 (DTC) 基因檢測市場的經營模式、績效及預測(2019-2024 年、2024-2029 年及 2034 年)
  • 健康計劃模型
  • 綜合基因組檢測模型
  • 醫療精準檢查模型
  • 有限特性測試模式
  • 全球直接面對消費者 (DTC) 基因檢測市場(按最終用戶、績效和預測)2019-2024 年、2024-2029 年、2034 年
  • 研究所
  • 血庫
  • 療養院
  • 醫院
  • 影像中心
  • 居家護理
  • 化妝品
  • 其他最終用戶
  • 全球直接面對消費者 (DTC) 基因檢測市場、載體檢測細分、按類型、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 體染色體隱性遺傳疾病
  • X連鎖疾病
  • 全球直接面對消費者 (DTC) 基因檢測市場、預測性檢測細分、按類型、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 遺傳疾病風險評估
  • 成人發病
  • 全球直接面對消費者 (DTC) 基因檢測市場細分(按血統和關係測試類型分類)、績效及預測(2019-2024 年、2024-2029 年及 2034 年)
  • 祖先分析
  • DNA匹配關係
  • 全球直接面對消費者 (DTC) 基因檢測市場,依營養基因體學檢測類型細分,績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 飲食建議
  • 代謝和健身洞察
  • 全球直接面對消費者 (DTC) 基因檢測市場及其他細分市場,按類型、實際規模及預測,2019-2024 年、2024-2029 年、2034 年
  • 藥物基因組學檢測
  • 健康特性測試

第7章 區域和國家分析

  • 全球直接面對消費者 (DTC) 基因檢測市場:按地區、績效和預測,2019-2024 年、2024-2029 年、2034 年
  • 全球直接面對消費者 (DTC) 基因檢測市場:按國家/地區、績效和預測,2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章:中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章:義大利市場

第20章:西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章:加拿大市場

第26章 南美洲市場

第27章:巴西市場

第28章 中東市場

第29章:非洲市場

第30章競爭格局與公司概況

  • 直接面對消費者(DTC)基因檢測市場:競爭格局
  • 直接面對消費者(DTC)基因檢測市場:公司簡介
    • 23andMe Overview, Products and Services, Strategy and Financial Analysis
    • AncestryDNA Overview, Products and Services, Strategy and Financial Analysis
    • MyHeritage Overview, Products and Services, Strategy and Financial Analysis
    • FamilyTreeDNA Overview, Products and Services, Strategy and Financial Analysis
    • Living DNA Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Vitagene
  • Orig3n
  • DNAfit
  • Helix
  • Color Genomics
  • Circle DNA
  • CRI Genetics
  • MapMyGenome
  • Invitae Corporation
  • TellmeGen
  • Pathway Genomics
  • Genebase Systems
  • EasyDNA
  • Nebula Genomics
  • Dante Labs

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年直接面對消費者(DTC)基因檢測市場:提供新機會的國家
  • 2029 年直接面對消費者 (DTC) 基因檢測市場:細分市場將帶來新機會
  • 2029年直接面對消費者(DTC)基因檢測市場:成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r26364

Direct-to-consumer genetic testing involves marketing genetic tests directly to consumers through various media channels such as radio, television, print adverts, and the internet. Customers can purchase these tests through online marketplaces and pharmacies. After acquiring a test kit, clients provide a DNA sample, gaining access to their genetic data without the need for a healthcare professional or health insurance provider. Results are typically accessed via a secure website, app, or a written report.

Direct-to-consumer (DTC) genetic testing encompasses various types, including carrier testing, predictive testing, ancestry and relationship testing, nutrigenomic testing, and other variants. Carrier screening assesses whether a person carries genetic alterations for specific disorders. These tests analyze saliva, urine, and blood samples using technologies such as single nucleotide polymorphism chips, whole genome sequencing, and targeted analysis. DTC genetic testing operates under different business models such as health planning, comprehensive genome tests, medical precision tests, and restricted trait tests. End-users of these tests include laboratories, blood banks, nursing homes, hospitals, imaging centers, home care, cosmetics, and other sectors.

The direct-to-consumer (DTC) genetic testing market research report is one of a series of new reports from The Business Research Company that provides direct-to-consumer (DTC) genetic testing market statistics, including direct-to-consumer (DTC) genetic testing industry global market size, regional shares, competitors with a direct-to-consumer (DTC) genetic testing market share, detailed direct-to-consumer (DTC) genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the direct-to-consumer (DTC) genetic testing industry. This direct-to-consumer (DTC) genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The direct-to-consumer (DTC) genetic testing market size has grown rapidly in recent years. It will grow from $1.84 billion in 2024 to $2.14 billion in 2025 at a compound annual growth rate (CAGR) of 16.2%. The growth in the historic period can be attributed to curiosity about ancestry and heritage, health and wellness trends, marketing and consumer education, privacy and control over genetic data, affordability and accessibility.

The direct-to-consumer (DTC) genetic testing market size is expected to see rapid growth in the next few years. It will grow to $3.9 billion in 2029 at a compound annual growth rate (CAGR) of 16.2%. The growth in the forecast period can be attributed to expanding test offerings, integration with personalized medicine, collaborations with health and wellness industries, advancements in genetic research, government support and regulations. Major trends in the forecast period include expanding test offerings and panels, educational initiatives for consumers, regulatory compliance and oversight, genomic data research and contributions, price reduction and accessibility.

The increasing prevalence of diseases and disorders with genetic transmission is anticipated to drive the growth of the direct-to-consumer (DTC) genetic testing market in the future. A genetic disorder is defined as an illness resulting from changes (mutations) in a person's DNA, encompassing single-gene, multifactorial, and chromosomal disorders. Direct-to-consumer genetic testing raises awareness of various genetic disorders, aiding individuals in making health predictions and providing personalized information about their health, disease risks, and other traits. This information supports effective health and lifestyle choices aimed at reducing disease risk. For example, in April 2023, the National Library of Medicine (NLM), a US-based medical library, reported that approximately 6.7 million Americans aged 65 and older were projected to be living with Alzheimer's dementia (AD) in 2023, a condition significantly influenced by genetics. This figure could rise to 13.8 million by 2060 unless medical breakthroughs are made to prevent, slow, or cure AD. Thus, the growing prevalence of genetically transmitted diseases and disorders is propelling the expansion of the direct-to-consumer (DTC) genetic testing market.

The anticipated expansion of digital health solutions is set to drive the growth of the direct-to-consumer (DTC) genetic testing market in the foreseeable future. Digital health leverages technology to enhance healthcare, improve patient outcomes, streamline processes, and empower individuals in managing their health. DTC genetic testing plays a pivotal role in this digital health growth by actively engaging consumers, integrating genetic data for personalization, facilitating telehealth services, connecting with wearable devices, and advocating for preventive care. An example of this trend is highlighted in a September 2022 report from the American Medical Association, a US-based professional organization. The report reveals a significant increase in the percentage of physicians who perceive digital health tools as beneficial for patient care, rising from 85% in 2016 to 93% in 2022. Furthermore, the average number of digital health tools utilized by physicians has also witnessed a notable growth, increasing from 2.2 in 2016 to 3.8 in 2022. Consequently, the surge in digital health solutions is a driving force behind the growth of the direct-to-consumer (DTC) genetic testing market.

Major players in the direct-to-consumer (DTC) genetic testing market are placing a strategic emphasis on substantial investments in genetic research to maintain their market positions. These investments serve as crucial financial support for genetic testing companies, enabling them to engage in research initiatives, advance technologies, broaden market outreach, ensure regulatory compliance, and foster innovation. As an illustrative example, in November 2022, Redcliffe Labs, an India-based provider of diagnostic services and laboratories, disclosed its intention to allocate an additional $10 million (approximately Rs 81 crore) for the expansion of its genetic and specialized testing portfolio. This financial commitment aims to further enhance the company's capabilities in genetic testing, encompassing areas such as prenatal, oncology, neurology, nephrology, and pharmacogenomics. Notably, Redcliffe Labs has already invested $6 million in the coverage of genetics and specialized testing, emphasizing a forward-looking approach towards next-generation technologies within the diagnostics sector.

Major players in the direct-to-consumer (DTC) genetic testing market are actively engaging in strategic collaborations to fortify their market positions. These strategic partnerships, particularly in the realm of technology-integrated genetic testing, serve to drive innovation, elevate diagnostic capabilities, expand global outreach, ensure adherence to regulatory standards, and propel advancements in personalized medicine. A case in point is the collaboration between Myriad Genetics, a US-based genomic testing company, and Epic Systems, a US-based software company, announced in June 2022. This collaboration focuses on integrating electronic health records (EHR) with genetic testing processes. By seamlessly incorporating Myriad tests into the Epic platform, healthcare providers can efficiently order and review genetic tests, streamlining the overall testing procedure. The integration is designed to improve patient care by delivering crucial genetic insights directly within the electronic health records (EHR) system. Myriad Genetics' strategic emphasis on technology-enabled tools aligns with its growth strategy, with the ultimate goal of enhancing accessibility and efficiency in genetic testing for both patients and clinicians.

In March 2022, LetsGetChecked, a virtual care company based in the United States, specializing in at-home testing, telehealth services, and pharmacy capabilities, successfully acquired Veritas Genetics for an undisclosed sum. This strategic acquisition positions LetsGetChecked to leverage whole-genome sequencing, enabling the initiation of a comprehensive lifecycle of personalized healthcare. The goal is to offer the market an extensive spectrum of health testing and care options. Veritas Genetics, the acquired company, is a biotechnology firm based in the United States, specializing in personal genomics.

Major companies operating in the direct-to-consumer (DTC) genetic testing market include 23andMe, AncestryDNA, MyHeritage, FamilyTreeDNA, Living DNA, Vitagene, Orig3n, DNAfit, Helix, Color Genomics, Circle DNA, CRI Genetics, MapMyGenome, Invitae Corporation, TellmeGen, Pathway Genomics, Genebase Systems, EasyDNA, Nebula Genomics, Dante Labs, Veritas Genetics, Xcode Life, Genomic Express, Genomelink, Genomind, WellnessFX, LetsGetChecked, iGene, Dnadoc, OneOme

North America was the largest region in the direct-to-consumer (DTC) genetic testing market share in 2024. Asia-Pacific was the second-largest region in the global direct-to-consumer (DTC) genetic testing market. The regions covered in the direct-to-consumer (dtc) genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the direct-to-consumer (dtc) genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The direct-to-consumer (DTC) genetic testing market includes revenues earned by entities by offering DTC genetic kits and services straight to end-customers, that are used in querying patients' DNA information. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Direct-To-Consumer (DTC) Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on direct-to-consumer (dtc) genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for direct-to-consumer (dtc) genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The direct-to-consumer (dtc) genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Carrier Testing; Predictive Testing; Ancestry And Relationship Testing; Nutrigenomic Testing; Other Types
  • 2) By Sample: Saliva; Urine; Blood
  • 3) By Technology: Single Nucleotide Polymorphism Chips; Whole Genome Sequencing; Targeted Analysis
  • 4) By Business Model: Health Planning Model; Comprehensive Genome Tests Model; Medical Precision Tests Model; Restricted Trait Tests Mode
  • 5) By End User: Laboratories; Blood Banks; Nursing Homes; Hospitals; Imaging Centers; Home Care; Cosmetics; Other End-User
  • Subsegments:
  • 1) By Carrier Testing: Autosomal Recessive Disorders; X-Linked Disorders
  • 2) By Predictive Testing: Risk Assessment For Genetic Conditions; Adult-Onset Conditions
  • 3) By Ancestry And Relationship Testing: Ancestry Composition Analysis; DNA Matching For Relationships
  • 4) By Nutrigenomic Testing: Dietary Recommendations; Metabolism And Fitness Insights
  • 5) By Other Types: Pharmacogenomic Testing; Health Trait Testing
  • Companies Mentioned: 23andMe; AncestryDNA; MyHeritage; FamilyTreeDNA; Living DNA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Direct-To-Consumer (DTC) Genetic Testing Market Characteristics

3. Direct-To-Consumer (DTC) Genetic Testing Market Trends And Strategies

4. Direct-To-Consumer (DTC) Genetic Testing Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Direct-To-Consumer (DTC) Genetic Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Direct-To-Consumer (DTC) Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Direct-To-Consumer (DTC) Genetic Testing Market Growth Rate Analysis
  • 5.4. Global Direct-To-Consumer (DTC) Genetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Direct-To-Consumer (DTC) Genetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Direct-To-Consumer (DTC) Genetic Testing Total Addressable Market (TAM)

6. Direct-To-Consumer (DTC) Genetic Testing Market Segmentation

  • 6.1. Global Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Carrier Testing
  • Predictive Testing
  • Ancestry And Relationship Testing
  • Nutrigenomic Testing
  • Other Types
  • 6.2. Global Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Saliva
  • Urine
  • Blood
  • 6.3. Global Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Nucleotide Polymorphism Chips
  • Whole Genome Sequencing
  • Targeted Analysis
  • 6.4. Global Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Business Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Health Planning Model
  • Comprehensive Genome Tests Model
  • Medical Precision Tests Model
  • Restricted Trait Tests Mode
  • 6.5. Global Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratories
  • Blood Banks
  • Nursing Homes
  • Hospitals
  • Imaging Centers
  • Home Care
  • Cosmetics
  • Other End-User
  • 6.6. Global Direct-To-Consumer (DTC) Genetic Testing Market, Sub-Segmentation Of Carrier Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Autosomal Recessive Disorders
  • X-Linked Disorders
  • 6.7. Global Direct-To-Consumer (DTC) Genetic Testing Market, Sub-Segmentation Of Predictive Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Risk Assessment For Genetic Conditions
  • Adult-Onset Conditions
  • 6.8. Global Direct-To-Consumer (DTC) Genetic Testing Market, Sub-Segmentation Of Ancestry And Relationship Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ancestry Composition Analysis
  • DNA Matching For Relationships
  • 6.9. Global Direct-To-Consumer (DTC) Genetic Testing Market, Sub-Segmentation Of Nutrigenomic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dietary Recommendations
  • Metabolism And Fitness Insights
  • 6.10. Global Direct-To-Consumer (DTC) Genetic Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmacogenomic Testing
  • Health Trait Testing

7. Direct-To-Consumer (DTC) Genetic Testing Market Regional And Country Analysis

  • 7.1. Global Direct-To-Consumer (DTC) Genetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Direct-To-Consumer (DTC) Genetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Direct-To-Consumer (DTC) Genetic Testing Market

  • 8.1. Asia-Pacific Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Direct-To-Consumer (DTC) Genetic Testing Market

  • 9.1. China Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 9.2. China Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Direct-To-Consumer (DTC) Genetic Testing Market

  • 10.1. India Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Direct-To-Consumer (DTC) Genetic Testing Market

  • 11.1. Japan Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 11.2. Japan Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Direct-To-Consumer (DTC) Genetic Testing Market

  • 12.1. Australia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Direct-To-Consumer (DTC) Genetic Testing Market

  • 13.1. Indonesia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Direct-To-Consumer (DTC) Genetic Testing Market

  • 14.1. South Korea Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 14.2. South Korea Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Direct-To-Consumer (DTC) Genetic Testing Market

  • 15.1. Western Europe Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 15.2. Western Europe Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Direct-To-Consumer (DTC) Genetic Testing Market

  • 16.1. UK Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Direct-To-Consumer (DTC) Genetic Testing Market

  • 17.1. Germany Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Direct-To-Consumer (DTC) Genetic Testing Market

  • 18.1. France Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Direct-To-Consumer (DTC) Genetic Testing Market

  • 19.1. Italy Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Direct-To-Consumer (DTC) Genetic Testing Market

  • 20.1. Spain Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Direct-To-Consumer (DTC) Genetic Testing Market

  • 21.1. Eastern Europe Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 21.2. Eastern Europe Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Direct-To-Consumer (DTC) Genetic Testing Market

  • 22.1. Russia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Direct-To-Consumer (DTC) Genetic Testing Market

  • 23.1. North America Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 23.2. North America Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Direct-To-Consumer (DTC) Genetic Testing Market

  • 24.1. USA Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 24.2. USA Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Direct-To-Consumer (DTC) Genetic Testing Market

  • 25.1. Canada Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 25.2. Canada Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Direct-To-Consumer (DTC) Genetic Testing Market

  • 26.1. South America Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 26.2. South America Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Direct-To-Consumer (DTC) Genetic Testing Market

  • 27.1. Brazil Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Direct-To-Consumer (DTC) Genetic Testing Market

  • 28.1. Middle East Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 28.2. Middle East Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Direct-To-Consumer (DTC) Genetic Testing Market

  • 29.1. Africa Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 29.2. Africa Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Direct-To-Consumer (DTC) Genetic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Direct-To-Consumer (DTC) Genetic Testing Market Competitive Landscape
  • 30.2. Direct-To-Consumer (DTC) Genetic Testing Market Company Profiles
    • 30.2.1. 23andMe Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. AncestryDNA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. MyHeritage Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. FamilyTreeDNA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Living DNA Overview, Products and Services, Strategy and Financial Analysis

31. Direct-To-Consumer (DTC) Genetic Testing Market Other Major And Innovative Companies

  • 31.1. Vitagene
  • 31.2. Orig3n
  • 31.3. DNAfit
  • 31.4. Helix
  • 31.5. Color Genomics
  • 31.6. Circle DNA
  • 31.7. CRI Genetics
  • 31.8. MapMyGenome
  • 31.9. Invitae Corporation
  • 31.10. TellmeGen
  • 31.11. Pathway Genomics
  • 31.12. Genebase Systems
  • 31.13. EasyDNA
  • 31.14. Nebula Genomics
  • 31.15. Dante Labs

32. Global Direct-To-Consumer (DTC) Genetic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Direct-To-Consumer (DTC) Genetic Testing Market

34. Recent Developments In The Direct-To-Consumer (DTC) Genetic Testing Market

35. Direct-To-Consumer (DTC) Genetic Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Direct-To-Consumer (DTC) Genetic Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Direct-To-Consumer (DTC) Genetic Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Direct-To-Consumer (DTC) Genetic Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer